The Affordable Insulin Now Act

Publication Date

Spring 3-23-2026

College

College of Pharmacy & Health Sciences

Department

Public Health, Department of

Student Level

Undergraduate

Faculty Mentor

Laurie Gavilo-Lane

Presentation Type

Article

Summary

Affordable Insulin Now Act

Problem Statement

In the United States, obesity drives the increased rate of diabetes. With higher rates of diabetes came higher demand for insulin as well, many patients have struggled with not being able to afford insulin due to high prices and that prevents consistent treatment. Lack of consistent treatment leads to more severe negative health outcomes.

According to an article published by the Center for Disease Control and Prevention more than 37 million individuals in the United States live with diabetes, and over 8 million depend on insulin therapy as well to many blood glucose levels because insulin is a required treatment for anyone with Type-1 diabetes and for most with Type-2 diabetes. Rising rates of obesity increase the number of individuals with diabetes because Type-2 diabetes is linked with obesity. (Centers for Disease Control and Prevention, 2023)

With that being said about 42 percent of adults in the United States live with obesity, and since research shows that adults with obesity face a risk that is five to seven times higher for diabetes than someone that maintains a healthy body weight (Centers for Disease Control and Prevention, 2023). Obesity increases the insulin resistance and raises the likelihood of developing type-2 diabetes. The difference in risk factors also contributes to higher diabetes incidence in certain populations. This also is reflected in the reported cases as well, with about 1.4 million diabetes diagnoses each year according to the same report from the CDC.

This document is currently not available here.

Share

COinS